title: Autologous hematopoietic stem cell transplantation for high-risk Hodgkin's disease: a single-center experience with the first 100 patients.
authors.affiliation: Department of Haematology and Bone Marrow Transplantation, Silesian Medical Academy, Poland.
authors.forename: J
authors.initials: J
authors.lastname: Holowiecki
authors.forename: S
authors.initials: S
authors.lastname: Giebel
authors.forename: J
authors.initials: J
authors.lastname: Wojnar
authors.forename: M
authors.initials: M
authors.lastname: Krawczyk-Kulis
authors.forename: B
authors.initials: B
authors.lastname: Stella-Holowiecka
authors.forename: L
authors.initials: L
authors.lastname: Kachel
authors.forename: M
authors.initials: M
authors.lastname: Wojciechowska
authors.forename: M
authors.initials: M
authors.lastname: Markiewicz
authors.forename: D
authors.initials: D
authors.lastname: Kata
mesh_terms: D000293:Adolescent; D000328:Adult; D001772:Blood Cell Count; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005260:Female; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods; D006689:Hodgkin Disease / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D016019:Survival Analysis; D013997:Time Factors; D014182:Transplantation, Autologous